These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24706226)

  • 1. Respiratory infections.
    Anderson EJ
    Cancer Treat Res; 2014; 161():203-36. PubMed ID: 24706226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of community-acquired lower respiratory tract infections during pregnancy.
    Lim WS; Macfarlane JT; Colthorpe CL
    Am J Respir Med; 2003; 2(3):221-33. PubMed ID: 14720004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation.
    Maschmeyer G; Donnelly JP
    Br J Haematol; 2016 Apr; 173(2):179-89. PubMed ID: 26729577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory bacterial infections in cystic fibrosis.
    Ciofu O; Hansen CR; Høiby N
    Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
    Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
    [No Abstract]   [Full Text] [Related]  

  • 7. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Manuel O; Estabrook M;
    Clin Transplant; 2019 Sep; 33(9):e13511. PubMed ID: 30817023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of therapeutic drug monitoring in pulmonary infections].
    Padoin C
    Rev Mal Respir; 2017 Jun; 34(6):693-705. PubMed ID: 28528008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of flexible bronchoscopy with polymerase chain reaction in the diagnosis and management of pulmonary infiltrates in allogeneic HSCT patients.
    Tang FF; Zhao XS; Xu LP; Zhang XH; Chen YH; Mo XD; Liu KY; Huang XJ
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29090481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A guide to the treatment of lower respiratory tract infections.
    Vogel F
    Drugs; 1995 Jul; 50(1):62-72. PubMed ID: 7588090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
    Balfour JA; Lamb HM
    Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in antibacterial choice for lower respiratory tract infections in elderly patients.
    Ferrara AM; Fietta AM
    Drugs Aging; 2004; 21(3):167-86. PubMed ID: 14979735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.
    Shams WE; Evans ME
    Drugs; 2005; 65(7):949-91. PubMed ID: 15892589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory infection complicating HIV infection.
    Davis JL; Fei M; Huang L
    Curr Opin Infect Dis; 2008 Apr; 21(2):184-90. PubMed ID: 18317044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections.
    Blondeau JM
    Expert Opin Investig Drugs; 2001 Feb; 10(2):213-37. PubMed ID: 11178338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.
    Blondeau JM; Hansen GT
    Expert Opin Pharmacother; 2001 Feb; 2(2):317-35. PubMed ID: 11336589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.
    Blasi F; Tarsia P; Cosentini R; Cazzola M; Allegra L
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1165-77. PubMed ID: 12831351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.
    Blasi F; Tarsia P; Aliberti S; Santus P; Allegra L
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():11-9. PubMed ID: 16310389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.